Skip to main content

Table 4 Difference-in-difference estimators (ATT) and their respective standard errors (SE) for analysis of two subgroups with (1) minor impairment due to back pain (GCPS Grades I and II) and (2) major impairment due to back pain (GCPS Grades III and IV), respectively, at study enrolment

From: Cost-effectiveness analysis of a chronic back pain multidisciplinary biopsychosocial rehabilitation (MBR) compared to standard care for privately insured in Germany

Minor impairment (1)

MBR (n =59)

Control (n=61)

DiD

Item

Baseline

Follow-up

Baseline

Follow-up

ATTa

SE

Total cost (€)

14636

15749

11242

11761

594

3564

 Back pain-specific cost (€)

2935

2143

2177

1956

-571

701

 Inpatient cost – back pain (€)

578

186

430

190

-152

348

 Outpatient cost – back pain (€)

2356

1957

1747

1766

-419

566

Sick leave in last 6 months due to back painb

3.3

5.8

3.3

15.3

-9.5*

2.91

Overall health status (EQ-5D)b

0.699

0.749

0.699

0.710

0.039

0.02

Major impairment (2)

MBR (n=53)

Control (n=50)

DiD

Item

Baseline

Follow-up

Baseline

Follow-up

ATTa

SE

Total Cost (€)

18850

13805

21442

18543

-2146

4617

 Back pain-specific cost (€)

4031

2296

3444

3533

-1824*

856

 Inpatient cost – back pain (€)

1295

336

424

926

-1462*

600

 Outpatient cost – back pain (€)

2736

1960

3021

2606

-362

633

Sick leave in last 6 months due to back painb

64

33.2

64

60.4

-27.2**

7

Overall health status (EQ-5D)b

0.494

0.591

0.494

0.544

0.047

0.02

  1. † < 0.1; * < 0.05; ** < 0.01; *** < 0.0001
  2. a Average treatment effect for the treated (ATT) represents the discounted mean differences in outcome
  3. b These results were not calculated with a DiD regression, but with an ANCOVA